Company: SABR
Filing Date: 2025-05-07
Form Type: 10-Q
Source: 0001597033-25-000061
Chunk: 64

Company: Sabre Corp
Filing Date: 2025-05-07
Form: 10-Q
Item: Part I, Item 1
Chunk 64
---
 of any one of our reporting units may more likely than not have fallen below its respective carrying amount. We have not identified any triggering events or changes in circumstances since the performance of our annual goodwill impairment test that would require us to perform another goodwill impairment test. We did not record any goodwill impairment charges for the three months ended March 31, 2025. 

9. Accumulated Other Comprehensive Loss 

As of March 31, 2025 and December 31, 2024, the components of accumulated other comprehensive loss, net of related deferred income taxes, are as follows (in thousands): March 31, 2025December 31, 2024Defined benefit pension and other postretirement benefit plans$(79,503)$(76,510)Unrealized foreign currency translation gain10,286 8,196 Unrealized loss on interest rate swaps(3,249)(2,793)Share of other comprehensive loss of equity method investments(2,852)(2,640)Total accumulated other comprehensive loss, net of tax $(75,318)$(73,747)The amortization of actuarial losses and periodic service credits associated with our retirement-related benefit plans is primarily included in Other, net in the consolidated statements of operations. As of March 31, 2025, we have contributed $10 million to our defined benefit pension plan in 2025. Based on current assumptions, we expect to make additional contributions of up to $6 million in 2025 to our defined benefit pension plan. See Note 7. Derivatives, for information on the income statement line items affected as the result of reclassification adjustments associated with derivatives.

10. Stock and Stockholders' Equity

Share Repurchase ProgramIn February 2017, we announced the approval of a multi-year share repurchase program (the “Share Repurchase Program”) to purchase up to $500 million of Sabre's common stock outstanding. Repurchases under the Share Repurchase Program may take place in the open market or privately negotiated transactions. On March 16, 2020, we announced the suspension of share repurchases under the Share Repurchase Program in conjunction with certain cash management measures we undertook as a result of the market conditions caused by COVID-19. During the three months ended March 31, 2025, we did not repurchase any shares pursuant to the Share Repurchase Program. As of March 31, 2025, the Share Repurchase Program remains suspended and approximately $